|
Video: What is a Stock Split?
|
|
Yumanity Therapeutics is a biopharmaceutical company focused on the discovery and development of disease-modifying therapies for neurodegenerative diseases. Co.'s primary program, YTX-7739, is in development for the potential treatment and disease modification of Parkinson's disease. YTX-7739 targets an enzyme known as stearoyl-CoA desaturase (SCD). Inhibition of SCD in multiple cellular systems, including patient-derived neurons, as well as in a mouse model of Parkinson's disease, has been demonstrated to reverse the toxicity of misfolded alpha-synuclein, a protein strongly associated with Parkinson's disease. According to our YMTX split history records, YMTX has had 1 split. | |
|
YMTX (YMTX) has 1 split in our YMTX split history database. The split for YMTX took place on December 23, 2020. This was a 1 for 20 reverse split, meaning for each 20 shares of YMTX owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 50 share position following the split.
When a company such as YMTX conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the YMTX split history from start to finish, an original position size of 1000 shares would have turned into 50 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into YMTX shares, starting with a $10,000 purchase of YMTX, presented on a split-history-adjusted basis factoring in the complete YMTX split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
02/12/2016 |
|
End date: |
12/16/2022 |
|
Start price/share: |
$123.60 |
|
End price/share: |
$1.89 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-98.47% |
|
Average Annual Total Return: |
-45.70% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$152.86 |
|
Years: |
6.85 |
|
|
|
Date |
Ratio |
12/23/2020 | 1 for 20 |
|
|